Navigation Links
NIH releases the first research plan to reduce the burden of digestive diseases
Date:4/2/2009

The National Institutes of Health today announced the release of the first long-range plan for tackling digestive diseases, which affect as many as 70 million Americans each year.

Opportunities and Challenges in Digestive Diseases Research: Recommendations of the National Commission on Digestive Diseases describes the impact of diseases ranging from foodborne infections to cancer and liver failure, and maps out priorities for research over the next 10 years. The report is online at: http://www2.niddk.nih.gov/AboutNIDDK/CommitteesAndWorkingGroups/NCDD/FinalResearchPlanPosting.htm.

"NIH-funded research has led to tremendous discoveries in peptic ulcer disease, viral hepatitis, and colorectal cancer. To build on these advances and break new ground, we'll be looking for investigator-initiated projects and developing new initiatives that respond to the commission's recommendations," said Griffin P. Rodgers, M.D., director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the NIH. "Of course, bringing in new investigators and utilizing NIH's peer review system to identify projects with high scientific merit will continue to be high priorities."

The report emphasizes the importance of cross-cutting research, encouraging multidisciplinary efforts to advance understanding of causes and improve diagnosis and treatment of digestive diseases. The high-impact goals recommended by the commission include:

  • Better understanding of basic biology of the digestive system

  • Improving the understanding of functional gastrointestinal disorders and motility disorders such as irritable bowel syndrome

  • Identifying additional infection-causing microbes

  • Developing more efficient tools to predict and detect cancers

  • Developing objective criteria to diagnose and evaluate inflammatory bowel diseases based on comprehensive genetic studies

  • Developing new treatment strategies for intestinal failure and regeneration, nutritional disorders and support, surgically modified gut (altered stomach following bariatric surgery for weight loss), and transplantation

  • Understanding the neuromuscular biology of diseases of the oropharynx (mouth and pharynx) and esophagus

  • Improving treatments for the diverse diseases of the stomach and small intestine

  • Developing more efficient ways to categorize diseases of the colon and rectum

  • Identifying the biologic and genetic triggers for acute and chronic pancreatitis

  • Testing new approaches to detect, prevent and treat diseases of the liver and biliary system (organs and ducts that produce and move bile to help digestion)

  • Using bioengineering, biotechnology, and imaging to improve patient outcomes and treatments

  • Each year about 105 million visits to doctors' offices are for digestive diseases, often driven by symptoms such as stomach pain, diarrhea, vomiting or nausea.

The diseases cost the United States $100 billion in direct medical costs every year. Prescription drugs for diseases such as gastroesophageal reflux are among the most commonly prescribed medications in the United States. For more information about digestive diseases, see www.digestive.niddk.nih.gov.

It was against the backdrop of human suffering and health care costs that the former NIH Director Elias A. Zerhouni established the commission in 2005. He charged the commission with reviewing current and needed research on digestive diseases. The report identifies recent research advances and new and emerging opportunities for future study.

The 16 appointed members of the commission represent academic and medical research, health care professionals and patient-advocacy groups. The commission also included 18 nonvoting ex officio members from the NIH and other federal agencies conducting digestive diseases research. For more information about the commission, see http://www2.niddk.nih.gov/AboutNIDDK/CommitteesAndWorkingGroups/NCDD.htm.

"The commission's recommendations provide a guidepost for digestive diseases research to be addressed over the next decade," said commission chair Stephen P. James, M.D., who also directs NIDDK's Division of Digestive Diseases and Nutrition. "We hope that this broad-based research plan leads to new findings that help reduce the pain and suffering experienced by the millions who suffer from digestive diseases."


'/>"/>

Contact: Leslie Curtis
niddkmedia@mail.nih.gov
301-496-3583
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Source:Eurekalert

Related medicine news :

1. APHA Releases Agenda for Health Reform
2. Pennsylvania Patient Safety Authority Releases March Advisory
3. Consumer Group Releases New Study About Defective Heart Devices and Implants; Patients Arrive in DC Tomorrow
4. Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results
5. HCLA Releases Report on Status of Medical Liability Reform
6. MayoClinic.com Releases New Design
7. Compendia Bioscience Releases Oncomine Concepts Edition 4.0
8. Cowden Associates Releases Eighth-Annual Employee Benefit Survey Results
9. Break the Cycle Releases 2009 State-By-State Teen Dating Violence Report Card
10. Hot Flash! - Sweet Pea Productions Releases Blitzed by Menopause: A Guys Guide to Menopause
11. Foundation for Biomedical Research Releases Groundbreaking PSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the game-changing dual ... opening of the Sober College Robert Pfeifer Memorial Learning Center at its location ... was attended by an overwhelming amount of alumni, family, colleagues and friends of ...
(Date:12/9/2016)... ... ... "I had a terrible time trying to get my grandson to use his ... had a more child-friendly design, then children would be more likely to look forward ... avoid the need to deliver medication via a nebulizer mask. The design will not ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Company LLC, announced the first national #QuackGivesBack campaign which supported local breast ... was our first franchise-wide Quack Gives Back initiative, and we’re very ...
(Date:12/8/2016)... ... 08, 2016 , ... With the increasing demand for dental implants, the National ... campaign to inform dentists and patients about the safety issues related to dental restorations. ... in the U.S. is projected to reach $6.4 billion in 2018 with more than ...
(Date:12/8/2016)... N.J. (PRWEB) , ... December 08, 2016 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... PSCI was set up in 2006 as a non-profit organization to unite pharmaceutical ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Allergy Diagnostics Market: Scope and ... that are used to determine the presence of ... drugs etc. in the samples by determining the ... The report on global allergy diagnostics market, analyzes ... The report consists of an executive summary that ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
Breaking Medicine Technology: